341.05USD-0.67%Mkt Cap: 10.16B $P/E: 42.97Today
Krystal Biotech, Inc., a commercial-stage biotechnology company, discovers, develops, manufactures, and commercializes genetic medicines to treat diseases with high unmet medical needs in the United States. The company c…
Industry Peers
BiotechnologyKey Statistics
Company
Market Cap10.16B $
Enterprise Value9.14B $
Revenue (TTM)440.48M $
Gross Profit366.08M $
Net Income (TTM)204.83M $
Revenue/Share15.08 USD
Last Price341.05 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees295
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS5011471027
Valuation
P/E (Trailing)42.97
P/E (Forward)35.86
PEG—
EV/EBITDA45.85
EV/Revenue20.75
P/S22.65
P/B7.34
EPS (TTM)7.97
EPS (Forward)9.40
52W Range
136.7383% of range382.54
52W High382.54 USD
52W Low136.73 USD
Profitability
Gross Margin94.08%
Oper. Margin49.00%
EBITDA Margin45.24%
Profit Margin52.64%
ROE16.80%
ROA15.36%
Growth
Revenue Growth24.10%
Earnings Growth38.80%
Cash Flow & Leverage
Operating CF200.87M $
CapEx (TTM)11.95M $
FCF Margin34.45%
FCF Yield1.49%
Net Debt-836.78M $
Net Debt/EBITDA-4.20
Balance Sheet
Debt/Equity0.01
Current Ratio8.32
Quick Ratio7.73
Book Value/Sh45.92 USD
Cash/Share28.57 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.3 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)385.00 USD
Upside (mean)+12.9%
Target Range284.00 USD – 474.00 USD
$284.00+12.9% to mean$474.00
# Analysts8
Ownership
Shares Out.29.60M
Float23.57M
Insiders10.83%
Institutions102.52%
Short Interest
Short Ratio5.8d
Short % Float17.72%
Short % Out.10.82%
Shares Short3.20M
Short (prev mo.)3.52M
Technical
SMA 50344.67 (-1.1%)
SMA 200281.75 (+21.0%)
Beta0.54
S&P 52W Chg18.16%
Avg Vol (30d)495.26K
Avg Vol (10d)168.83K
Technical Indicators
RSI (14)53.2
MACD-2.6058
MACD Signal-3.2099
MACD Hist.+0.6041
BB Upper365.97 USD
BB Middle336.51 USD
BB Lower307.06 USD
BB Width17.51%
ATR (14)13.58 USD
Vol Ratio (20d)0.27x